PREPARING AN EXTRACORPOREAL BLOOD TREATMENT APPARATUS
20220047788 · 2022-02-17
Inventors
- Roger Nilsson (Höör, SE)
- Björn Ericson (Lund, SE)
- Jonas Fors (Malmö, SE)
- Karl Henrik Forsland (Genarp, SE)
Cpc classification
A61M1/365
HUMAN NECESSITIES
International classification
Abstract
A control system is configured to implement a method of preparing a blood treatment apparatus (1) for blood treatment. The method comprises installing, by use of a disposable arrangement, first and second flow circuits (C1, C2) separated by a semi-permeable membrane (25), the first flow circuit (C1) being connected for fluid communication with the apparatus (1) and the second flow circuit (C2) being connected to form a closed loop that includes a sterilizing filter (46) and, optionally, a container (30). The method further comprises performing backfiltration to transfer a human-compatible fluid from the first flow circuit (C1) to the second flow circuit (C2) through the semi-permeable membrane (25), and circulating (304) the human-compatible fluid in the closed loop of second flow circuit (C2), to thereby sterilize the human-compatible fluid by the sterilizing filter (46) and, optionally, collect a resulting sterile fluid in the container (30) for later use.
Claims
1-27. (canceled)
28. A control system for a blood treatment apparatus, said control system comprising: a memory; and a processor in operable communication with the memory, the processor configured to: instruct an operator to install a first flow circuit for conducting a fluid provided by the blood treatment apparatus through a dialyzer; instruct the operator to install a second flow circuit which is separated from the first flow circuit by a semi-permeable membrane of the dialyzer, the second flow circuit comprising connectors for connection to a vascular system of a subject during blood treatment, wherein the second flow circuit is configured to be disconnected from the vascular system and form a closed loop that includes a sterilizing filter; operate the blood treatment apparatus to pump a human-compatible fluid into the first flow circuit so that a portion of the human-compatible fluid flows through the semi-permeable membrane into the second flow circuit; and operate the blood treatment apparatus to circulate said portion of the human-compatible fluid in the closed loop of the second flow circuit, to thereby sterilize said portion of the human-compatible fluid by the sterilizing filter.
29. The control system of claim 28, wherein the second flow circuit is installed to further include a container, said processor being further configured to: operate the blood treatment apparatus to collect a sterile fluid in the container, the sterile fluid being generated by circulating said portion of the human-compatible fluid in the closed loop.
30. The control system of claim 29, wherein said portion of the human-compatible fluid is circulated through the container.
31. The control system of claim 29, wherein the processor is configured to instruct the operator to form the closed loop by directly or indirectly connecting the connectors to an inlet port and an outlet port, respectively, on the container.
32. The control system of claim 31, wherein the second flow circuit is installed with the sterilizing filter being co-located with the outlet port so that said portion of the human-compatible fluid flows through the sterilizing filter when leaving the container via the outlet port.
33. The control system of claim 31, wherein the second flow circuit is installed with the sterilizing filter directly or indirectly connected to one of the inlet and outlet ports of the container.
34. The control system of claim 29, wherein the second flow circuit is installed with the sterilizing filter located within the container.
35. The control system of claim 31, wherein the inlet and outlet ports define an inlet opening and an outlet opening, respectively, inside the container, wherein the processor is configured to instruct the operator to install the second flow circuit such that the container locates the inlet opening above the outlet opening.
36. The control system of claim 29, wherein the processor is further configured to instruct the operator to connect the connectors to the vascular system of the subject, and operate the blood treatment apparatus to perform said blood treatment, and instruct the operator, subsequent to said blood treatment, to establish fluid communication between the container holding the sterile fluid and the second flow circuit, and operate the blood treatment apparatus to drive blood in the second flow circuit back into the vascular system of the subject while drawing at least a portion of the sterile fluid in the container into the second flow circuit.
37. The control system of claim 29, wherein the processor is further configured to: instruct the operator to connect the connectors to the vascular system of the subject and install the container holding the sterile fluid for fluid communication with the second flow circuit, and operate the blood treatment apparatus to perform said blood treatment, and to introduce of a portion of the sterile fluid in the container into the second flow circuit during said blood treatment.
38. The control system of claim 28, wherein the processor is further configured to ventilate the second flow circuit to expel gaseous substances.
39. The control system of claim 28, wherein the processor is configured to circulate said portion of the human-compatible fluid in the closed loop of the second flow circuit so that said portion of the human-compatible fluid is passed at least once through the sterilizing filter.
40. The control system of claim 28, wherein the processor is further configured to, while the human-compatible fluid is pumped into the first flow circuit, cause a flow restriction in the first flow circuit downstream of the dialyzer.
41. The control system of claim 28, wherein the processor is configured to circulate said portion of the human-compatible fluid in the closed loop of the second flow circuit for a predefined time period after completion of said pumping.
42. The control system of claim 28, wherein the human-compatible fluid comprises one of a saline solution, a treatment fluid for use during said blood treatment, and water.
43. A blood treatment apparatus, comprising a fluid supply unit configured to supply a human-compatible fluid to a first flow circuit when the first flow circuit is connected to the blood treatment apparatus, a pump operable to engage with a second flow circuit when the second flow circuit is connected to the blood treatment apparatus, and the control system of claim 28.
44. A method of preparing a blood treatment apparatus for blood treatment, said method comprising: installing a first flow circuit for conducting a fluid provided by the blood treatment apparatus through a dialyzer, installing a second flow circuit which is separated from the first flow circuit by a semi-permeable membrane of the dialyzer, the second flow circuit comprising connectors for connection to a vascular system of a subject during blood treatment, wherein the second flow circuit is configured to be disconnected from the vascular system and form a closed loop that includes a sterilizing filter, pumping, before blood treatment and by the blood treatment apparatus, a human-compatible fluid into the first flow circuit so that a portion of the human-compatible fluid flows through the semi-permeable membrane into the second flow circuit, and circulating, before blood treatment and by the blood treatment apparatus, said portion of the human-compatible fluid in the closed loop of the second flow circuit, to thereby sterilize said portion of the human-compatible fluid by the sterilizing filter.
45. A non-transitory, computer-readable medium storing instructions which, when executed by a processor, cause the processor to perform the method of claim 44.
46. A disposable arrangement for use in a blood treatment apparatus, comprising: at least one fluid-conducting device which is configurable to define a flow circuit that extends through a blood chamber of a dialyzer and comprises connectors for connection to a vascular system of a subject during blood treatment, and a sterilizing filter, wherein the disposable arrangement is configurable to define the flow circuit to form a closed loop that includes the sterilizing filter.
47. The disposable arrangement of claim 46, further comprising a container and being further configurable to define the flow circuit to include the container.
48. The disposable arrangement of claim 47, wherein the container comprises an inlet port and an outlet port, and wherein the disposable arrangement is further configurable to include the container in the closed loop by connection, indirectly or directly, of the connectors to the inlet and outlet ports.
49. The disposable arrangement of claim 48, wherein the disposable arrangement is further configurable to co-locate the sterilizing filter with the outlet port so that said portion of the human-compatible fluid flows through the sterilizing filter when leaving the container via the outlet port.
50. The disposable arrangement of claim 48, which is further configurable to locate the sterilizing filter intermediate the container and one of the connectors.
51. The disposable arrangement of claim 47, wherein the sterilizing filter is arranged inside the container.
52. The disposable arrangement of claim 46, further comprising a dialyzer, said dialyzer comprising a fluid chamber, the blood chamber, and a semi-permeable membrane separating the fluid chamber and the blood chamber, wherein the fluid chamber is configured for connection to a fluid supply unit of the blood treatment apparatus.
53. The disposable arrangement of claim 46, which is sterilized and located within one or more protective casings.
54. The disposable arrangement of claim 46, wherein the sterilizing filter is a sterilizing-grade filter which is configured for bacterial retention.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0052] Embodiments of the invention will now be described in more detail with reference to the accompanying drawings.
[0053]
[0054]
[0055]
[0056]
[0057]
[0058]
[0059]
DETAILED DESCRIPTION OF EXAMPLE EMBODIMENTS
[0060] Embodiments of the present invention will now be described more fully hereinafter with reference to the accompanying drawings, in which some, but not all, embodiments of the invention are shown. Indeed, the invention may be embodied in many different forms and should not be construed as limited to the embodiments set forth herein; rather, these embodiments are provided so that this disclosure may satisfy applicable legal requirements. Like numbers refer to like elements throughout.
[0061] Also, it will be understood that, where possible, any of the advantages, features, functions, devices, and/or operational aspects of any of the embodiments of the present invention described and/or contemplated herein may be included in any of the other embodiments of the present invention described and/or contemplated herein, and/or vice versa. In addition, where possible, any terms expressed in the singular form herein are meant to also include the plural form and/or vice versa, unless explicitly stated otherwise. As used herein, “at least one” shall mean “one or more” and these phrases are intended to be interchangeable. Accordingly, the terms “a” and/or “an” shall mean “at least one” or “one or more,” even though the phrase “one or more” or “at least one” is also used herein. As used herein, except where the context requires otherwise owing to express language or necessary implication, the word “comprise” or variations such as “comprises” or “comprising” is used in an inclusive sense, that is, to specify the presence of the stated features but not to preclude the presence or addition of further features in various embodiments of the invention.
[0062] As used herein, “human-compatible fluid” refers to any fluid, which by its composition, and when sufficiently sterilized, is compatible with the human body if administered to its circulatory system in amounts relevant for the particular application. For example, the human-compatible fluid may be any such fluid that is available at a blood treatment apparatus, including but not limited to a physiological saline solution, a treatment fluid, and water.
[0063] As used herein, “sterile fluid” refers to any fluid with a sufficient sterility to be administered to the circulatory system of a mammal.
[0064] As used herein, “indirectly connected” denotes that two components are connected with each other via one or more intermediate components.
[0065] As used herein, a “sterilizing filter” is any filter capable of producing a sterile fluid by filtration. In one embodiment, the sterilizing filter is further arranged to produce a sterile and non-pyrogenic fluid. In one embodiment, the sterilizing filter is a sterilizing-grade filter, which is configured for bacterial retention and, optionally, also for bacterial endotoxin retention. In one embodiment, the sterilizing filter is a validated sterilizing-grade filter, i.e. a sterilizing filter that has passed a filter qualification process for demonstrating bacterial retention of the filter, e.g. using the well-known standard Brevundimonas diminuta, or any other standardized or non-standardized filter qualification process. In one embodiment, the sterilizing grade filter is arranged to filter the human-compatible fluid into a sterile fluid with an amount of bacteria that is zero Colony-Forming Units/mL (CFU/mL) and an amount of bacterial endotoxins that is less than 0.05 Endotoxin Units/mL (EU/mL). In one embodiment, the sterilizing grade filter includes a membrane having pores with average diameters suitable to produce sterile fluid, including the capability of removing endotoxins. In one example, the mean pore diameter for the sterilizing grade filter is less than 1 μm, such as 0.1-0.5 μm, e.g. 0.1 or 0.2 μm. Bacteria typically have a diameter of a few micrometers, and will then not pass through the pores. The filter membrane may further comprise a high molecular weight additive bearing cationic charges, for example a cationic charged polymer. Examples of other kinds of positively charged additives can be found in EP1710011. In such examples, the filter membrane will be positively charged and thus reject bacterial endotoxins, whereby less bacteria and bacterial endotoxins will pass the membrane. In an exemplary embodiment, bacteria and bacterial endotoxins may also be retained based on adsorption to the membrane. The membrane may be polyethersulfone-based. Other suitable polymers may be AN69, PAN, PMMA, cellulose, etc. Suitable sterilizing grade filters may, for example, be Pall IV-5 or GVS Speedflow filters, or be filters provided by the present applicant.
[0066] In the following, embodiments of the invention will be exemplified with reference to an apparatus configured for treatment of chronic renal failure, denoted “dialysis machine” below.
[0067]
[0068] In the illustrated example, a control system or controller 2 in the machine 1 is configured to synchronize and control the operation of the components of the machine 1, e.g. by electric control signals. The operation of the control system 2 may be at least partly controlled by software instructions that are supplied on a computer-readable medium for execution by a processor 2A in conjunction with a memory 2B in the control system 2. A display unit 3 is operable to provide information and instructions for a user, such as a nurse, a physician or a patient. The machine 1 may also enable the user to enter data into the machine, e.g. via mechanical buttons or keys, or virtual buttons or keys on a touch panel, e.g. in the display unit 3. A fluid supply unit 4 is configured to supply one or more suitable fluids during operation of the machine L Such fluids may include one of more of a treatment fluid (dialysis fluid) for use during blood treatment, a disinfectant for use in disinfection of the machine between treatments, a saline solution, and purified water. The fluids may be supplied from replaceable containers attached to the machine 1 or may be generated on demand by the machine 1 or another apparatus in fluid communication with the machine 1. In the illustrated example, the machine comprises two machine ports 5, 6 in fluid connection to the supply unit 4. The machine 1 further comprises a holder 7 for a dialyzer (20 in
[0069] The set of disposables in
[0070] The disposables in
[0071]
[0072] In
[0073] Before the line arrangements 40A, 40B and the dialyzer 20 are utilized in any dialysis treatment, both should be primed. Priming is a process of replacing air with a sterile fluid in the line arrangements 40A, 40B and the dialyzer 20 by allowing the sterile fluid to flow through these components. Without priming, air may enter the vascular system of the subject S during treatment and cause air embolism. Further, excess air may lead to clotting of the dialyzer 20 during treatment, which may negatively affect the subject S. Priming is a time-consuming and often sloppy process that requires access to relatively large quantities of sterile fluid and involves several manual steps by the operator. Embodiments of the invention aim at facilitating priming.
[0074] During dialysis treatment, there may be a need to inject a quantity of a sterile fluid into the circulating blood in the second fluid circuit C2. For example, it is known to inject a bolus of a sterile hypertonic solution into the blood of the subject S to counteract hypertension, which is a common and severe intradialytic acute complication. Embodiments of the invention aim at facilitating access to a sufficiently sterile fluid for such injection.
[0075] When dialysis treatment is completed, it is common practice to return all or most of the blood remaining in the second flow circuit C2 to the vascular system of the subject S. This process is known as “rinse back” and involves introducing a fluid into the second flow circuit C2 so as to push back the remaining blood into the subject S. The fluid should be sterile since there is a risk of fluid entering the vascular system during rinse back. Embodiments of the invention aim at facilitating access to a sufficiently sterile fluid for rinse back.
[0076] By insightful reasoning, the inventors have found that it is possible use any human-compatible fluid supplied by the dialysis machine 1 as a priming fluid by introducing a sterilizing filter (cf. 46 in
[0077] In one simple and user friendly implementation, the sterilizing filter is connected intermediate the patient connectors 43, 44 of the second flow circuit C2 to form a closed loop during priming. Thereby, the flow path of the human-compatible fluid in the second flow path C2 during priming corresponds to the flow path of blood during dialysis treatment. Thus, the entire blood path is primed in one operation, i.e. by the circulation of the human-compatible fluid in the closed loop.
[0078] The inventors have further realized that it may be advantageous to include a container (cf. 30 in
[0079] The inventors have further realized that it may be advantageous to arrange the container in the second flow circuit C2 during priming such that it is included in the closed loop and the human-compatible fluid is circulated through the container. Thereby, it is possible to collect the sterilized human-compatible fluid in the container as part of the circulation, instead of performing a separate filling operation after circulation. Thus, the complexity of the process is reduced.
[0080] In one simple and user friendly implementation, the container has at least one inlet port and at least one outlet port, which are configured to be connected, directly or indirectly, to the patient connectors 43, 44 of the second flow circuit C2 during priming.
[0081] In the following, an embodiment of the invention will be described with reference to a flow chart in
[0082] The system diagram in
[0083] Reverting to
[0084] In step 302, the second flow circuit C2 is installed on the dialysis machine 1 by use of the disposables in
[0085] In step 303, the dialysis machine 1 is operated to pump a human-compatible fluid (denoted “priming fluid” in the following) into the first flow circuit C1 such that a portion of the priming fluid passes through the dialyzer membrane 25 into the second flow circuit C2, as indicated by arrows in
[0086] In step 304, the dialysis machine 1 is operated to circulate the priming fluid along the closed loop of the second flow circuit C2, e.g. as indicated by arrows in
[0087] In step 305, which may be performed at any time during step 304 or thereafter, the second flow circuit C2 is ventilated to expel excess air, e.g. via the drip chamber 41 or the container 30. For example, the operator may be instructed by the control system 2 to open a dedicated clamp or valve (not shown). Alternatively, the control system 2 may generate a control signal for opening such a clamp or valve. Optionally, the ventilation may be assisted by a pump (not shown) in the machine 1, which is connected for fluid communication with the second fluid circuit C2 and operated based on a control signal from the control system 2. It is also conceivable that the second flow circuit C2 is pre-configured to be open to the surroundings, e.g. via the drip chamber 41 or the container 30, when it is installed in step 302.
[0088] In step 306, the sterile fluid is collected in the container 30. In the example of
[0089] It is realized that the arrangement of disposables in
[0090] When the priming sequence I is completed, the operator may be instructed to connect the second flow circuit C2 to the subject S (step 307). In the example of
[0091] If a need arises, for any reason, to introduce a sterile fluid into the circulatory system of the subject S, e.g. to counteract hypertension, the operator may be given the possibility of introducing one or more dosages (“boluses”) of sterile fluid from the container 30 into the second flow circuit C2 (step 309). An example is shown in
[0092] Reverting to
[0093] One implementation, which does not require a branch line 50, is shown in
[0094] If the line arrangement 40B has a branch line 50 between the clamp 11 and the patient connector 44, the implementation in
[0095] If the line arrangement 40B has a branch line 50 between the clamp 11 and the blood pump 8, the implementation in
[0096] It may be noted that the container 30 is configured such that the inlet opening 34 is located above (in the direction of gravity) the outlet opening 35 when the container 30 is suspended during priming (
[0097] In the illustrated embodiments, the sterilizing filter 46 is co-located with the outlet port 32 so that the fluid in the container 30 will flow through the filter 46 when leaving the container 30. This configuration ensures that the sterile fluid that is held in the container 30 after priming will be subjected to an additional sterilization when leaving the container 30, e.g. for bolus injection (
[0098]
[0099] After step 705, the dialysis machine 1 operates the blood pump 8 to circulate the priming fluid for a first time period ΔT1 (step 706). During ΔT1, the operator may check for bubbles at the dialyzer blood outlet (i.e. at the top of the dialyzer 20) and tap on the dialyzer 20 to remove such bubbles (step 707). If the dialyzer 20 was turned upside down in step 701, the operator may also be instructed during ΔT1 to arrange the dialyzer 20 with its blood outlet facing upwards, e.g. in the holder 7. After expiry of the time period ΔT1, the dialysis machine 1 stops the blood pump 8 (step 709) and waits for a second time period ΔT2 (step 710), to allow the first chamber 25 of the dialyzer 20 to be completely filled with priming fluid. After expiry of the time period ΔT2, the priming is completed and the operator is instructed to disconnect the container 30 and the filter from the second flow circuit C2 (step 711).
[0100] While the invention has been described in connection with what is presently considered to be the most practical and preferred embodiments, it is to be understood that the invention is not to be limited to the disclosed embodiments, but on the contrary, is intended to cover various modifications and equivalent arrangements included within the spirit and the scope of the appended claims.
[0101] For example, the foregoing description is equally applicable to any machine or apparatus which is configured to perform extracorporeal blood treatment by use of a dialyzer or an equivalent filtration unit, including but not limited to hemodialysis, hemofiltration, hemodiafiltration, plasmapheresis, extracorporeal blood oxygenation, extracorporeal liver support/dialysis, ultrafiltration, etc. With respect to hemofiltration and hemodiafiltration, the sterile fluid in the container 30 may be used as replacement or substitution fluid, which is introduced into the second flow circuit C2 during blood treatment. Compared to the above-described bolus injection and rinse back, the sterile fluid would have to be produced in larger quantities before the blood treatment.